KKR & Co. agreed to acquire Swedish consumer-health company Karo Healthcare from EQT AB, defying the downbeat sentiment ...

A KKR-Stonepeak consortium would buy British healthcare REIT Assura for 1.61 billion pounds ($2.06 billion), the companies ...

EQT and KKR today announced that EQT VIII fund ("EQT") has agreed to sell Karo Healthcare ("Karo" or the "Company") to KKR. The acquisition marks the next chapter for Karo, as it continues to ...

The sale would mark a profitable exit for Karo’s owner EQT, which struck a deal to take the business private in 2022 valuing ...

KKR & Co. has walked away from a private equity consortium discussing a takeover of Gerresheimer AG, the German maker of packaging for drugs and cosmetics, people familiar with the matter said.

Shares of Gerresheimer fell after a media report stating that investment firm KKR walked away from a consortium seeking to acquire the German pharmaceutical and cosmetics packager. At near mid-day ...

Global law firm White & Case LLP has advised leading global investment firm EQT on its sale of portfolio company Karo Healthcare, one of Europe's leading consumer health platforms, to KKR.

KKR (KKR) nears a deal to acquire Tokyo-based medical geat maker Topcon Corp (TOPCF) amid rising buyout activity in Japan.

KKR, the U.S.-based private equity giant, has divested a 5.8 per cent stake in JB Chemicals & Pharmaceuticals for Rs 1,460 ...

The company’s product portfolio spans categories such as skin health, foot health, and intimate health, as well as digestive health and vitamins, minerals and supplements.

Block deal trades of 90 lakh shares of JB Chemicals and Pharmaceuticals stock, with KKR likely selling, causing share price ...